| |
| |
|
| Insider
Information: |
Lettmann Jason |
| Relationship: |
|
| City: |
Portola Valley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
171,620 |
|
|
Indirect Shares
|
6,496,140 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$190,962,981 |
|
|
| Total
Shares |
6,667,760 |
|
|
| Total
Value |
$190,962,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ra Pharmaceuticals, Inc. |
RARX |
Director |
|
0 |
2016-10-31 |
4,066,503 |
Premium* |
|
|
Alx Oncology Holdings Inc |
ALXO |
|
2024-03-14 |
171,620 |
2021-12-13 |
2,429,637 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXO |
Alx Oncology Holdings Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-14 |
4 |
B |
$11.31 |
$49,771 |
D/D |
4,400 |
171,620 |
0.01 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
167,220 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Director |
– • • |
2021-12-13 |
4 |
S |
$25.29 |
$8,901,804 |
I/I |
(325,377) |
285,956 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Director |
– • • |
2021-12-10 |
4 |
S |
$30.77 |
$822,719 |
I/I |
(26,274) |
291,758 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Director |
– • • |
2021-12-09 |
4 |
S |
$31.08 |
$2,463,502 |
I/I |
(76,905) |
294,909 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Director |
– • • |
2021-12-08 |
4 |
S |
$33.23 |
$1,411,871 |
I/I |
(42,458) |
304,131 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Director |
– • • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,691,171 |
120,212 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Director |
– • • |
2020-07-21 |
4 |
B |
$19.00 |
$7,600,000 |
I/I |
400,000 |
22,000 |
2.25 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Director |
– • • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
88,704 |
107,220 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Director |
– • – |
2016-10-31 |
4 |
B |
$13.00 |
$5,120,999 |
I/I |
393,923 |
4,066,503 |
2.1 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Director |
– • – |
2016-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
3,592,759 |
3,672,580 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Director |
– • – |
2016-10-31 |
4 |
S |
$13.00 |
$4,420 |
I/I |
(340) |
79,821 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Director |
– • – |
2016-10-31 |
4 |
OE |
$0.07 |
$4,411 |
I/I |
63,019 |
80,161 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Director |
– • – |
2016-10-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,142 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
